Brind.
  1. Nociscan is running the CLARITY clinical trial, which utilizes multiple sites including USC, Northwestern Medicine, and Johns Hopkins University.

Aclarion is expanding Nociscan utilization in the U.K. and partnered with PRIA Healthcare for market access.

2 reports, 1 independent Updated Jul 29
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Aclarion is expanding Nociscan utilization in the U.K. and partnered with PRIA Healthcare for market access.

Who's involved

What this event is mainly about
U.K.

How it developed

Newest first. Tap a step to see who reported it.
  1. Aclarion's patent protects Nociscan workflow precision.Sub-event
  2. Aclarion leverages Nociscan technology for spine care and is expanding into the U.K.1 source

Keep exploring

Part of

Nociscan is running the CLARITY clinical trial, which utilizes multiple sites including USC, Northwestern Medicine, and Johns Hopkins University. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped
1 more outlet ran the same wire story